Ksilometazolin/Dekspantenol Pliva (Xylometazoline Hydrochloride, Dexpanthenol)

Ksilometazolin/Dekspantenol Pliva is used to manage nasal congestion and mucosal irritation within the upper respiratory tract.

• Nasal congestion due to common cold: reduces swelling of nasal mucosa and improves airflow.
• Sinusitis: alleviates blockage and facilitates sinus drainage.
• Allergic rhinitis: relieves congestion and nasal irritation associated with allergic responses.
• Dry or irritated nasal mucosa: provides moisturizing effect and supports epithelial repair.

• Xylometazoline acts as an α‑adrenergic agonist, binding to α1‑ and α2‑adrenergic receptors on the vascular smooth muscle of the nasal mucosa, producing vasoconstriction and decreasing edema. Dexpanthenol is converted intracellularly to pantothenic acid (vitamin B5), which participates in co‑enzyme A synthesis and promotes epithelial cell proliferation, thereby enhancing mucosal hydration and repair.

The most frequently reported reactions to Ksilometazolin/Dekspantenol Pliva involve the nasal cavity, while rare events may affect systemic health.

Common Side Effects

• Nasal burning or stinging sensation
• Mild nasal dryness
• Sneezing
• Headache
• Unpleasant taste

Serious or Rare Side Effects

• Severe nasal bleeding
• Allergic reaction such as rash, swelling or anaphylaxis
• Hypertension or rapid heart rate
• Rebound nasal congestion (rhinitis medicamentosa) after prolonged use

When using Ksilometazolin/Dekspantenol Pliva, several precautions should be observed to ensure safe and effective therapy.

• Duration of use: limit treatment to 3‑5 consecutive days to avoid rebound congestion.
• Cardiovascular conditions: avoid in patients with severe hypertension, coronary artery disease or hyperthyroidism.
• Pregnancy and lactation: safety not established; use only if clearly needed after medical advice.
• Pediatric use: follow age‑specific recommendations and do not exceed the dose indicated for children.
• Concomitant nasal decongestants: do not combine with other topical decongestants to prevent excess vasoconstriction.
• Store at room temperature: keep in original container, protect from moisture and direct heat.

Ksilometazolin/Dekspantenol Pliva may interact with certain systemic or topical agents, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Other nasal decongestants (e.g., oxymetazoline, phenylephrine): additive vasoconstriction may increase risk of hypertension.
• Systemic sympathomimetic drugs (e.g., pseudoephedrine, ephedrine): can potentiate cardiovascular effects.

Moderate Interactions (Monitor Closely)

• Antihypertensive medications: nasal decongestant may reduce their efficacy, requiring blood pressure monitoring.
• Tricyclic antidepressants or MAO inhibitors: may enhance sympathomimetic activity and raise blood pressure.
• Beta‑blockers: possible attenuation of bronchodilator response in asthmatic patients.